HBM Partners
Venture Capital
Swiss healthcare investor with $2.1B AUM, focusing on biopharma, medtech, diagnostics in Europe, North America, and emerging markets.
Zug, Switzerland · 7+ investments · 43 portfolio companies
Seed
Early Stage
Late Stage
Growth
Biotech
Diagnostics
Healthcare
Medtech
- Headquarters
- Zug, Switzerland
- Founded
- 2001
- Website
- hbmpartners.com
- Portfolio Companies
- 43
- Total Investments
- 7
- Last Investment
- Jan 2024
- Geographic Focus
- Europe, North America, India, China
Investment Thesis
Source, analyze, and support growth of healthcare companies through venture, growth, and buy-out financings, leveraging global network.
HBM Partners is a Venture Capital firm based in Zug, Switzerland. It has made 7 investments in Biotech and Diagnostics, including Neuron23, Genalyte and Ignis Therapeutics.
Portfolio43



CB
Cathay BiotechFB
FORE BiotherapeuticsSH
Swixx HealthcareC
CorxelS
Sphingotec
VP
Visen PharmaceuticalsM
Mahzi
F
FarmaLatam

RR
River Renal
A
AdaRxNB
Nuance Biotech
O
OneSource
AO
ALX OncologyNT
Numab TherapeuticsInvestment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/hbm-partners"><img src="https://indexed.vc/api/badge/investor/hbm-partners" alt="HBM Partners on Indexed.vc" width="260" height="76" /></a>